癌症中的SWI/SNF复合物
SWI/SNF complex in cancer.
作者信息
Lu Chao, Allis C David
机构信息
Laboratory of Chromatin Biology and Epigenetics, Rockefeller University, New York, New York, USA.
出版信息
Nat Genet. 2017 Jan 31;49(2):178-179. doi: 10.1038/ng.3779.
Abstract
Four studies in this issue report new mechanisms underlying the function of the chromatin remodeling SWI/SNF complex in controlling gene expression and suppressing tumor development, providing valuable insights into the treatment of cancers harboring mutations in genes encoding SWI/SNF complex subunits.
摘要
本期的四项研究报告了染色质重塑SWI/SNF复合物在控制基因表达和抑制肿瘤发展中发挥作用的新机制，为治疗编码SWI/SNF复合物亚基的基因发生突变的癌症提供了有价值的见解。
相似文献
1
SWI/SNF complex in cancer.癌症中的SWI/SNF复合物
Nat Genet. 2017 Jan 31;49(2):178-179. doi: 10.1038/ng.3779.
2
BAFfling pathologies: Alterations of BAF complexes in cancer.BAF 相关病变：癌症中 BAF 复合物的改变。
Cancer Lett. 2018 Apr 10;419:266-279. doi: 10.1016/j.canlet.2018.01.046. Epub 2018 Jan 31.
3
COMPASS and SWI/SNF complexes in development and disease.COMPASS 和 SWI/SNF 复合物在发育和疾病中的作用。
Nat Rev Genet. 2021 Jan;22(1):38-58. doi: 10.1038/s41576-020-0278-0. Epub 2020 Sep 21.
4
Differential targeting of two distinct SWI/SNF-related Drosophila chromatin-remodeling complexes.两种不同的与SWI/SNF相关的果蝇染色质重塑复合物的差异靶向作用。
Mol Cell Biol. 2004 Apr;24(8):3077-88. doi: 10.1128/MCB.24.8.3077-3088.2004.
5
SMARCB1 is required for widespread BAF complex-mediated activation of enhancers and bivalent promoters.广泛的BAF复合物介导的增强子和二价启动子激活需要SMARCB1。
Nat Genet. 2017 Nov;49(11):1613-1623. doi: 10.1038/ng.3958. Epub 2017 Sep 25.
6
NSD1 mediates antagonism between SWI/SNF and polycomb complexes and is required for transcriptional activation upon EZH2 inhibition.NSD1 介导了 SWI/SNF 和 polycomb 复合物之间的拮抗作用，并且在 EZH2 抑制时对于转录激活是必需的。
Mol Cell. 2022 Jul 7;82(13):2472-2489.e8. doi: 10.1016/j.molcel.2022.04.015. Epub 2022 May 9.
7
The SWI/SNF chromatin remodelling complex: Its role in maintaining genome stability and preventing tumourigenesis.SWI/SNF染色质重塑复合体：其在维持基因组稳定性和预防肿瘤发生中的作用。
DNA Repair (Amst). 2015 Aug;32:127-133. doi: 10.1016/j.dnarep.2015.04.023. Epub 2015 May 1.
8
Multiple interactions of the oncoprotein transcription factor MYC with the SWI/SNF chromatin remodeler.癌蛋白转录因子 MYC 与 SWI/SNF 染色质重塑因子的多种相互作用。
Oncogene. 2021 May;40(20):3593-3609. doi: 10.1038/s41388-021-01804-7. Epub 2021 Apr 30.
9
Inactivating mutations in SWI/SNF chromatin remodeling genes in human cancer.人类癌症中 SWI/SNF 染色质重塑基因的失活突变。
Jpn J Clin Oncol. 2013 Sep;43(9):849-55. doi: 10.1093/jjco/hyt101. Epub 2013 Jul 30.
10
Drosophila Kismet regulates histone H3 lysine 27 methylation and early elongation by RNA polymerase II.果蝇Kismet通过RNA聚合酶II调节组蛋白H3赖氨酸27甲基化和早期延伸。
PLoS Genet. 2008 Oct;4(10):e1000217. doi: 10.1371/journal.pgen.1000217. Epub 2008 Oct 10.
引用本文的文献
1
Safety and efficacy of HH2853, a novel EZH1/2 dual inhibitor, in patients with refractory solid tumours or non-Hodgkin lymphomas: a phase I study.新型EZH1/2双重抑制剂HH2853在难治性实体瘤或非霍奇金淋巴瘤患者中的安全性和有效性：一项I期研究
EClinicalMedicine. 2025 Aug 7;86:103398. doi: 10.1016/j.eclinm.2025.103398. eCollection 2025 Aug.
2
Inhibition of recurrence and metastasis in triple-negative breast cancer through nanoparticle-mediated silencing of LPCAT1 to remodel ATP energy metabolism.通过纳米颗粒介导沉默LPCAT1以重塑ATP能量代谢来抑制三阴性乳腺癌的复发和转移。
Sci China Life Sci. 2025 May 7. doi: 10.1007/s11427-024-2887-x.
3
[ARID1B Gene Deletion Promotes the Proliferation, Migration and Invasion
of NSCLC Cells].[ARID1B基因缺失促进非小细胞肺癌细胞的增殖、迁移和侵袭]
Zhongguo Fei Ai Za Zhi. 2025 Mar 20;28(3):165-175. doi: 10.3779/j.issn.1009-3419.2025.101.04.
4
Mutation of SMARCA4 Induces Cancer Cell-Intrinsic Defects in the Enhancer Landscape and Resistance to Immunotherapy.SMARCA4突变在增强子景观中诱导癌细胞内在缺陷并导致对免疫疗法的抗性。
Cancer Res. 2025 Jun 2;85(11):1997-2013. doi: 10.1158/0008-5472.CAN-24-2054.
5
Swi/Snf chromatin remodeling regulates transcriptional interference and gene repression.Swi/Snf染色质重塑调节转录干扰和基因抑制。
Mol Cell. 2024 Aug 22;84(16):3080-3097.e9. doi: 10.1016/j.molcel.2024.06.029. Epub 2024 Jul 22.
6
ARID1B Immunohistochemistry Is an Important Test for the Diagnosis of Dedifferentiated and Undifferentiated Gynecologic Malignancies.ARID1B免疫组织化学是诊断去分化和未分化妇科恶性肿瘤的重要检测方法。
Cancers (Basel). 2023 Aug 24;15(17):4229. doi: 10.3390/cancers15174229.
7
BCL7B, a SWI/SNF complex subunit, orchestrates cancer immunity and stemness.BCL7B，一个 SWI/SNF 复合物亚基，协调癌症免疫和干性。
BMC Cancer. 2023 Aug 30;23(1):811. doi: 10.1186/s12885-023-11321-3.
8
Mutational landscape of SWI/SNF complex genes reveal correlation to predictive biomarkers for immunotherapy sensitivity in lung adenocarcinoma patients.SWI/SNF 复合物基因的突变景观揭示了与肺腺癌患者免疫治疗敏感性预测生物标志物的相关性。
ESMO Open. 2023 Jun;8(3):101585. doi: 10.1016/j.esmoop.2023.101585. Epub 2023 Jun 14.
9
Swi/Snf Chromatin Remodeling Regulates Transcriptional Interference and Gene Repression.Swi/Snf染色质重塑调控转录干扰和基因抑制。
bioRxiv. 2023 Apr 27:2023.04.27.538572. doi: 10.1101/2023.04.27.538572.
10
ARID1A Inactivation Increases Expression of circ0008399 and Promotes Cisplatin Resistance in Bladder Cancer.ARID1A 失活可增加 circ0008399 的表达并促进膀胱癌对顺铂的耐药性。
Curr Med Sci. 2023 Jun;43(3):560-571. doi: 10.1007/s11596-023-2731-8. Epub 2023 May 5.
本文引用的文献
1
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice.ARID1A缺失会损害增强子介导的基因调控，并在小鼠中引发结肠癌。
Nat Genet. 2017 Feb;49(2):296-302. doi: 10.1038/ng.3744. Epub 2016 Dec 12.
2
SMARCB1-mediated SWI/SNF complex function is essential for enhancer regulation.SMARCB1介导的SWI/SNF复合体功能对于增强子调控至关重要。
Nat Genet. 2017 Feb;49(2):289-295. doi: 10.1038/ng.3746. Epub 2016 Dec 12.
3
Dynamics of BAF-Polycomb complex opposition on heterochromatin in normal and oncogenic states.正常和致癌状态下异染色质上BAF-多梳复合物对抗的动力学
Nat Genet. 2017 Feb;49(2):213-222. doi: 10.1038/ng.3734. Epub 2016 Dec 12.
4
Smarca4 ATPase mutations disrupt direct eviction of PRC1 from chromatin.Smarca4 ATP酶突变破坏了PRC1从染色质上的直接驱逐。
Nat Genet. 2017 Feb;49(2):282-288. doi: 10.1038/ng.3735. Epub 2016 Dec 12.
5
Maintaining cell identity: PRC2-mediated regulation of transcription and cancer.维持细胞身份：PRC2 介导的转录调控与癌症。
Nat Rev Cancer. 2016 Dec;16(12):803-810. doi: 10.1038/nrc.2016.83. Epub 2016 Sep 23.
6
Synthetic lethality by targeting EZH2 methyltransferase activity in ARID1A-mutated cancers.通过靶向ARID1A突变癌症中的EZH2甲基转移酶活性实现合成致死
Nat Med. 2015 Mar;21(3):231-8. doi: 10.1038/nm.3799. Epub 2015 Feb 16.
7
ARID1B is a specific vulnerability in ARID1A-mutant cancers.ARID1B 是 ARID1A 突变型癌症的特异性弱点。
Nat Med. 2014 Mar;20(3):251-4. doi: 10.1038/nm.3480. Epub 2014 Feb 23.
8
Proteomic and bioinformatic analysis of mammalian SWI/SNF complexes identifies extensive roles in human malignancy.哺乳动物 SWI/SNF 复合物的蛋白质组学和生物信息学分析鉴定出其在人类恶性肿瘤中的广泛作用。
Nat Genet. 2013 Jun;45(6):592-601. doi: 10.1038/ng.2628. Epub 2013 May 5.
9
Epigenetic antagonism between polycomb and SWI/SNF complexes during oncogenic transformation.抑癌基因与癌基因的表达调控
Cancer Cell. 2010 Oct 19;18(4):316-28. doi: 10.1016/j.ccr.2010.09.006.
10
Oncogenesis caused by loss of the SNF5 tumor suppressor is dependent on activity of BRG1, the ATPase of the SWI/SNF chromatin remodeling complex.由SNF5肿瘤抑制因子缺失引起的肿瘤发生依赖于BRG1的活性，BRG1是SWI/SNF染色质重塑复合物的ATP酶。
Cancer Res. 2009 Oct 15;69(20):8094-101. doi: 10.1158/0008-5472.CAN-09-0733. Epub 2009 Sep 29.
Zotero 插件